跳至主要内容
CAS 0 条记录

CAS 1119-34-2

CAS 1119-34-2 与法规 1223/2009 附件 II–VI 中的 0 条欧盟附件记录相匹配。

CAS 1119-34-2 的记录

0 共
未找到此 CAS 编号的记录。

化学身份与性质

CAS 1119-34-2 的 PubChem 二维化学结构
CAS 1119-34-2PubChem CID 66250

L-Arginine, monohydrochloride

Arginine hydrochloride is a L-alpha-amino acid. — ChEBI

IUPAC 名称
(2S)-2-amino-5-(diaminomethylideneamino)pentanoic acid;hydrochloride
分子式
C6H15ClN4O2
分子量
210.66 g/mol
精确质量
210.0883534 Da
拓扑极性表面积
128.0 Ų
氢键供体
5
氢键受体
4
共价单元
2
已定义的立体中心
1

又称

Arginine HydrochlorideL-ARGININE HCLR-GeneR-gene 10F7LTH1E20YNSC-203450NSC-7914Hydrochloride, arginine
另有 16 个已报告名称
NSC7914RefChem:5562214-275-1L-Arginine hydrochlorideL-Arginine monohydrochlorideH-Arg-OH.HClArginine HClArginine monohydrochlorideArgamineArgiveneDetoxarginL-(+)-Arginine monohydrochlorideLevarginL-Arginine, hydrochloride (1:1)Minophagen A(+)-L-Arginine hydrochloride
外部数据库标识符

来自其他科学数据库的证据

NIH PubChem PUG-View
标识符精确匹配66250

Attributed physical-property, hazard, environmental and use annotations.

  • Exposure Routes: Absorbed from the lumen of the small intestine into the enterocytes. Absorption is efficient and occurs by an active transport mechanism. 来源: Toxin and Toxin Target Database (T3DB)
  • Note: This chemical does not meet GHS hazard criteria for 67.8% (269 of 397) of all reports. 来源: European Chemicals Agency (ECHA)
  • Signal: Warning 来源: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H315 (31.7%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (32.2%): Causes serious eye irritation [Warning Serious eye damage/eye irritation] 来源: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P264, P264+P265, P280, P302+P352, P305+P351+P338, P321, P332+P317, P337+P317, and P362+P364 (click each P-code to see the statement) 来源: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 397 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 269 of 397 reports by companies.; There are 3 notifications provided by 128 of 397 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 来源: European Chemicals Agency (ECHA)
  • Cosmetic Ingredient Review Finding(s): Safe in the present practices of use and concentration. Ingredient, concentration, and use information are available in documents discoverable at https://cir-reports.cir-safety.org 来源: Cosmetic Ingredient Review (CIR)
  • Toxicity Summary: Many of supplemental L-arginine's activities, including its possible anti-atherogenic actions, may be accounted for by its role as the precursor to nitric oxide or NO. NO is produced by all tissues of the body and plays very important roles in the cardiovascular system, immune system and nervous system. NO is formed from L-arginine via the enzyme nitric oxide synthase or synthetase (NOS), and the effects of NO are mainly mediated by 3,'5' -cyclic guanylate or cyclic GMP. NO activates the enzyme guanylate cyclase, which catalyzes the synthesis of cyclic GMP from guanosine triphosphate or GTP. Cyclic GMP is converted to guanylic acid via the enzyme cyclic GMP phosphodiesterase. NOS is a heme-containing enzyme with some sequences similar to cytochrome P-450 reductase. Several isoforms of NOS exist, two of which are constitutive and one of which is inducible by immunological stimuli. The constitutive NOS found in the vascular endothelium is designated eNOS and that present in the brain, spinal cord and peripheral nervous system is designated nNOS. The form of NOS induced by immunological or inflammatory stimuli is known as iNOS. iNOS may be expressed constitutively in select tissues su 来源: Toxin and Toxin Target Database (T3DB)

映射方: Existing checksum-valid CAS to unique PubChem CID match. 检索时间: 2026-08-31. 打开来源记录

科学分类和危害注释仅提供背景信息,不能取代上方所示针对具体市场的监管决定。

其他来源的覆盖范围和匹配状态
来源结果已检查
NIH PubChem PUG-View精确匹配2026-08-31

已记录的无匹配结果是该来源已被检查的有效证据;这并不表示该物质在别处不存在。

于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

本站如何使用 CAS 1119-34-2

CAS 1119-34-2 是化学文摘社 (Chemical Abstracts Service) 的标识符,用于将本页对应到特定物质。在当前数据集中,有 0 条欧盟附件记录共用该标识符,可帮助您交叉核对同一物质是出现在一种还是多种监管情境中。

当供应商规格书、SDS 或原料档案给出 CAS 1119-34-2,而您需要在一处查看所有关联的附件 II–VI 记录时,请使用本页。上方的条目卡片是查看浓度限值、警示语、附件归属和产品类型条件的最快途径。